MKH Auth on Muck Rack

MKH Auth

As seen in: Frontline Gastroenterology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with MKH

Contact MKH, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

OC37 BSPGHAN survey on the access and prescription of vedolizumab and ustekinumab in paediatric inflammatory bowel disease patients

|
By JJ Ashton, Ky Lee, MKH Auth, KDJ Jones
| Frontline Gastroenterology
While the incidence of IBD is rising, therapeutic options for paediatric IBD are limited, especially for younger children. Unlike in adults, vedolizumab and ustekinumab are not generally licenced for paediatric use in the UK. We aimed to obtain data on the real-world access to, and use of, these therapies in the paediatric population. We surveyed all 21 designated UK IBD centres to assess the incident use of vedolizumab and ustekinumab from 1/1/2021–31/12/2021.
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with MKH

Contact MKH, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified